Masteron is the trade name for drostanolone, a dihydrotestosterone-derived anabolic steroid that comes in two ester forms: the short drostanolone propionate and the longer drostanolone enanthate. It began life as a breast-cancer treatment, exploiting its mild anti-estrogenic activity, and it now occupies a specific niche in physique circles. This guide explains what it genuinely does, why it is so dependent on low body fat, and how it is typically used. It is reference information, not a recommendation to use.
Because drostanolone is derived from DHT, it cannot aromatise to estrogen. Like stanozolol, this means no estrogenic water retention and a dry appearance, but drostanolone brings an additional property: mild activity as an anti-estrogen, competing at the aromatase enzyme and, historically, at the estrogen receptor in breast tissue.
What it actually does
Drostanolone is not a mass drug. Its effect is on appearance and, to a lesser degree, on how you feel and look under contest-level conditioning.
- A dry, hard, slightly "grainy" muscle look, prized in the final phase of a cut. It holds no water and does not convert to estrogen.
- A mild anti-estrogenic effect that can take some of the edge off estrogenic side effects from aromatising compounds in a stack — though it is weak and not a replacement for a proper aromatase inhibitor when one is needed.
- A modest strength and muscle-preservation effect in a deficit. As a DHT derivative it is androgenic relative to its anabolic rating, which contributes to the hard look and a sense of well-being some users report, alongside the usual androgenic downsides.
Why it needs low body fat
This is the single most important thing to understand about Masteron: its effect is essentially invisible on someone who is not already lean. The hardening, drying, defined look it is famous for only appears when there is little subcutaneous fat and water between the muscle and the skin. On a person at higher body fat, drostanolone does very little you can see, and much of its reputation comes from before-and-after comparisons in people who were already extremely lean.
- The compound reveals conditioning; it does not create it. Diet and body fat do the real work.
- This is why it is a late-stage, pre-contest or peak-week tool rather than an off-season mass compound. Used at higher body fat, people are usually disappointed and conclude it "doesn't work" — because for that purpose, it largely doesn't.
The DHT and androgenic side effects
As a potent androgen derived from DHT, drostanolone carries the DHT-type side effects more prominently than milder compounds.
- Accelerated male-pattern hair loss in the genetically predisposed, and oily skin or acne.
- The usual HPTA suppression — it must be run with a testosterone base like other steroids, and it does not support libido on its own.
- It does not aromatise, so it adds no estrogen; but because estrogen is protective for lipids, non-aromatising DHT-derivatives like this contribute to a less favourable lipid picture, though generally less harshly than oral 17-alpha-alkylated compounds. Drostanolone is not liver-toxic in the way orals are, since it is an injectable and not 17-alpha-alkylated.
How it is run and stacked
Masteron is a supporting compound, layered onto a testosterone base during a cutting or contest-prep phase, essentially never run alone. The ester choice determines dosing frequency:
- Drostanolone propionate is short-acting and dosed frequently, often every other day, and is the classic pre-contest choice because levels can be manipulated quickly near a deadline.
- Drostanolone enanthate is longer-acting and dosed less often, more convenient across a longer cutting block.
- It is commonly stacked with testosterone and often with another dry compound such as stanozolol for a combined hardening effect in the final weeks. Reported weekly doses sit in a moderate range; going higher mainly amplifies androgenic side effects rather than the look.
Health considerations
The monitoring for drostanolone is the standard androgen panel with attention to lipids and to androgenic effects rather than to liver or estrogen problems. It is generally regarded as one of the milder injectables on the liver, but its androgenicity and lipid effect are real and should not be dismissed.
- Baseline and follow-up bloods: lipids, full blood count for haematocrit, testosterone, estradiol.
- Watch for hair loss and skin changes, which are more likely with DHT-derivatives.
- As with any cycle, plan for suppression and recovery, and keep a testosterone base to maintain function.
Bottom line
Drostanolone is a niche, honest compound: it adds a dry, hard finish to an already-lean physique and offers a mild anti-estrogenic bonus in a stack, with no aromatisation and no liver toxicity. But its entire value depends on low body fat — on anyone who is not already lean it does almost nothing visible — and it carries the DHT-type androgenic side effects of hair loss and skin issues. It is a supporting actor for the last weeks of a cut, not a mass builder and not a standalone drug.